Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 8/31/2023Recent Official and Executive Moves
  • 8/31/2023MC2 Thera and Huadong Pharma Enter LIcense Deal for Plague Psoriasis D...
  • 8/31/2023NHSA to Cancel Hospital Payment Rights for Drug and Consumable Procure...
  • 8/31/2023NMPA and Chinese Customs Announce Addition of Taizhou as a Drug Import...
  • 8/31/2023IQVIA: Chinese Retail Pharmacy Sales up 8.9% in MAT Q2/2023
  • 8/30/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (73...
  • 8/30/2023Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
  • 8/30/2023Upcoming Event: 15th Annual Pharma Market Research Conference (Free)
  • 8/30/2023Upcoming Event: 2023 Pharma CI USA Conference & Exhibition (Free)
  • 8/29/2023CanSino to Acquire 10% Stake in Malaysian Vaccine Maker Solution
  • 8/29/2023NMPA Set to Raise the Bar for Conditional Approval Process of New Drug...
  • 8/29/2023Former Star Official of China's Healthcare Reform and VBP Architect ...
  • 8/29/2023NMPA Announces OTC Switch of Paracetamol Orally Dispersion Tablet
  • 8/29/2023NMPA Announces Package Insert Revision of Two Drug Products
  • 8/28/2023Chinese Pharma CEOs Emphasize Strategic R&D Selection in Tough Fundrai...
  • 8/28/2023CDE Solicits Second Round Comments on Two Pharmaceutical Change Resear...
  • 8/28/2023Verastem Oncology Enters Partnerships with GenFleet Therapeutics to Ad...
  • 8/25/2023Drug R&D and Product Registration News Digest August 2023 (4)
  • 8/25/2023State Council Adopts New Action Plan for High-quality Development of P...
  • 8/25/2023IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
  • 8/25/2023Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)
  • 8/25/2023NMPA Solicits Comments on the Working Procedures for Evaluation and Ap...
  • 8/25/2023NMPA Issues Announcement for Applicability of ICH Guidelines Q12
  • 8/25/2023CDE Seeks Comments on Draft ICH Guidelines M7(R2)
  • 8/24/2023CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
  • 8/24/2023Chinese Consortium Eyes Acquisition of Dominant Polish Pharma Distribu...
  • 8/24/2023Review of China Performance of Leading MNCs in China H1/2023 (Updated)
  • 8/23/2023Chinese and Indonesian Cos Form New Partnerships in Biotech & Healthca...
  • 8/23/2023NMPA Issues the List of Reference Formulations for GQCE Studies (72nd ...
  • 8/23/2023NMPA Appoints New Director General of the CDE
  • Page:29/33 Total number of articles:961: [First][<<] [27] [28] [29] [30] [31] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group